COVID-19 vaccine registration in India for people aged between 18 and 44 years will go live from 4pm Wednesday, April 28.
This will be the third step of India’s vaccination campaign, which will broaden the current vaccination requirements to include people aged 45 and up. COVID-19 vaccination registration is required, and qualified individuals must have a valid Indian identification evidence, such as an Aadhaar card or a PAN card. India recently registered over 350,000 cases in a single day, the world’s highest total.
The government has made it mandatory for people aged 18 to 44 to register on the CoWIN portal and schedule a coronavirus vaccination appointment, stating that walk-ins would not be permitted at first to prevent “chaos” at immunisation centers until the inoculation campaign ramps up significantly.
Covaxin, produced by Hyderabad-based Bharat Biotech, and Covishield, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of India, are the two COVID-19 vaccines currently being used in the vaccination campaign (SII).
Covishield, manufactured by the Serum Institute of India, will cost states Rs 400 per dose and private hospitals Rs 600 per dose, while Bharat Biotech’s Covaxi will cost states Rs 600 per dose and private hospitals Rs 1,200 per dose.
But don’t get your hopes up too high; while India has vaccinated a large number of people, we still have an absurdly large population, and the new push would simply increase the number of people who will be vaccinated.